CS159092A3 - Chemical modification 2''-amino group of elsamycin a - Google Patents

Chemical modification 2''-amino group of elsamycin a Download PDF

Info

Publication number
CS159092A3
CS159092A3 CS921590A CS159092A CS159092A3 CS 159092 A3 CS159092 A3 CS 159092A3 CS 921590 A CS921590 A CS 921590A CS 159092 A CS159092 A CS 159092A CS 159092 A3 CS159092 A3 CS 159092A3
Authority
CS
Czechoslovakia
Prior art keywords
elsamycin
compound
alkyl
formula
carbon atoms
Prior art date
Application number
CS921590A
Other languages
Czech (cs)
English (en)
Inventor
Toda Soichiro
Yamashita Haruhiro
Naito Takayuki
Nishiyama Yuji
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CS159092A3 publication Critical patent/CS159092A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CS921590A 1991-05-30 1992-05-26 Chemical modification 2''-amino group of elsamycin a CS159092A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70747291A 1991-05-30 1991-05-30

Publications (1)

Publication Number Publication Date
CS159092A3 true CS159092A3 (en) 1992-12-16

Family

ID=24841834

Family Applications (1)

Application Number Title Priority Date Filing Date
CS921590A CS159092A3 (en) 1991-05-30 1992-05-26 Chemical modification 2''-amino group of elsamycin a

Country Status (15)

Country Link
US (1) US5374711A (fi)
EP (1) EP0516156A1 (fi)
JP (1) JPH05208992A (fi)
KR (1) KR920021572A (fi)
AU (1) AU655023B2 (fi)
CA (1) CA2069717A1 (fi)
CS (1) CS159092A3 (fi)
FI (1) FI922442A (fi)
HU (1) HU210418B (fi)
IE (1) IE921766A1 (fi)
IL (1) IL102000A0 (fi)
MX (1) MX9202570A (fi)
OA (1) OA09752A (fi)
TW (1) TW218881B (fi)
ZA (1) ZA923818B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6994932B2 (en) * 2001-06-28 2006-02-07 Foamex L.P. Liquid fuel reservoir for fuel cells
EP1518288A2 (en) * 2002-06-28 2005-03-30 Foamex L.P. Fuel reservoir for liquid fuel cells
US7291410B2 (en) * 2002-09-18 2007-11-06 Kinkelaar Mark R Orientation independent liquid fuel reservoir
EP2222276A1 (en) * 2007-12-19 2010-09-01 Spectrum Pharmaceuticals, Inc. Stable elsamitrucin salt formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE448379B (sv) * 1978-03-31 1987-02-16 Roussel Uclaf O-substituerade oximderivat av 7-amino-tiazolyl-acetamidocefalosporansyra
JPS5750996A (en) * 1980-09-11 1982-03-25 Microbial Chem Res Found 3-o-demthylistamycin b derivative
JPS58128395A (ja) * 1982-01-27 1983-07-30 Microbial Chem Res Found 3−0−デメチルイスタマイシンbの低毒性誘導体
JPS58213774A (ja) * 1982-06-04 1983-12-12 Kowa Co 新規アミノ配糖体
US4562177A (en) * 1982-08-17 1985-12-31 The Ohio State University Research Foundation 3'-Amino-2' halo-anthracycline antibiotics
US4518589A (en) * 1983-10-03 1985-05-21 Bristol-Myers Company BBM-2478 Antibiotic complex
US4515783A (en) * 1983-10-24 1985-05-07 Merck & Co., Inc. 4-Amino-4-dehydroxy derivatives of efrotomycin and related compounds
ATE72447T1 (de) * 1985-10-23 1992-02-15 Ishihara Sangyo Kaisha Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
US5237055A (en) * 1991-05-30 1993-08-17 Bristol-Myers Squibb Company Chemical modification of 2"-amino group in elsamicin A
US5229371A (en) * 1991-05-30 1993-07-20 Bristol-Myers Squibb Company Chemical modification of elsamicin A at the 3' and/or 4' OH groups

Also Published As

Publication number Publication date
AU1723992A (en) 1992-12-03
FI922442A0 (fi) 1992-05-27
HU210418B (en) 1995-04-28
HU9201733D0 (en) 1992-08-28
EP0516156A1 (en) 1992-12-02
TW218881B (fi) 1994-01-11
KR920021572A (ko) 1992-12-18
OA09752A (en) 1993-11-30
IL102000A0 (en) 1992-12-30
ZA923818B (en) 1993-11-25
US5374711A (en) 1994-12-20
IE921766A1 (en) 1992-12-02
AU655023B2 (en) 1994-12-01
FI922442A (fi) 1992-12-01
JPH05208992A (ja) 1993-08-20
CA2069717A1 (en) 1992-12-01
HUT61775A (en) 1993-03-01
MX9202570A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
DE69326388T2 (de) Verfahren zur Herstellung von Staurosporin-Derivaten
Cholody et al. 5-[(Aminoalkyl) amino] imidazo [4, 5, 1-de] acridin-6-ones as a novel class of antineoplastic agents. Synthesis and biological activity
JP2854971B2 (ja) 制癌化合物
PL143281B1 (en) Process for preparing 4"-api-9-desketo-9a-methyl-9a-aza-9a-homoerythromycin a
JP3176062B2 (ja) イミダゾアクリジン及び抗腫瘍薬としてのその使用
PL171813B1 (pl) Sposób wytwarzania nowych amidowych pochodnych antybiotyku A 40926 PL PL PL PL PL
CS159092A3 (en) Chemical modification 2''-amino group of elsamycin a
HU217551B (hu) 6[(2-Hidroxi-etil)-amino-alkil]-5,11-dioxo-5,6-dihidro-11H-indén[1,2-c]izokinolin-származékok, valamint eljárás előállításukra, továbbá hatóanyagként e vegyületeket tartalmazó gyógyászati készítmények
US8101758B2 (en) Stereoselective process and crystalline forms of a camptothecin
US5237055A (en) Chemical modification of 2"-amino group in elsamicin A
WO1994029308A1 (en) Lavendamycin analogs, their use and preparation
CS221801B2 (en) Method of praparation of the derivative of 4-deoxy-4-aminoerythromycine a
CS158792A3 (en) Chemical modification of 3' and/or 4'-oh group elsamycin a
IE921764A1 (en) Preparation of 6-0-alkylelsamicin a derivatives
US5229371A (en) Chemical modification of elsamicin A at the 3' and/or 4' OH groups
TW219366B (fi)
CS158992A3 (en) Process for preparing 6-0-acylelasmycin a derivatives